Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_assertion description "[Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment is the standard therapy for non-small cell lung cancer (NSCLC) harbouring EGFR-activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_assertion evidence source_evidence_literature NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_assertion SIO_000772 25726043 NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_assertion wasDerivedFrom befree-2016 NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_assertion wasGeneratedBy ECO_0000203 NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.
- befree-2016 importedOn "2016-02-19" NP1267095.RAtdzcCLIzdpqJEKZfyb9aNiU-xUH3gpXOuxhZxo62Ntk130_provenance.